Research

Emtek Group: Busy with Corporate Actions

market-avatar

Algo Research Team


The content provided here is for informational purpose only. It is not an advise or recommendation. Please do your own research.
content-img

Key Summary:


  • Stock prices have mostly outperformed the market past 1 year
  • BUKA could start to deploy its cash after change in IPO proceeds
  • SCMA sees value from potential IPO from its subsidiary, Vidio

Over the past 1 year, Emtek Group’s share prices have gradually increased, as seen in the outperformance of EMTK (+33%), SCMA (+50%), and CASS (+109%). However, SAME (-4%) and BUKA (-17%) continue to underperform.


We have written extensively about the group (read here and here) and see positive momentum, particularly regarding potential corporate actions that could create upside opportunities.


How was our research?


DISCLAIMER: Algo is an independent research platform and is not affiliated with any financial institution. We are not a licensed securities dealer, financial advisor, broker, or investment bank. The contents shared across our website, and social media platforms are intended for informational purposes only and reflect our views and opinions. It is not meant to be construed as financial advice and/or a recommendation to buy or sell an asset. Past performance does not guarantee future results. As a research platform, our contents are made to provide data-driven information and research-based articles, and should not be used as a basis for making any investment decisions. We strongly encourage you to conduct your own research and consult with a licensed financial advisor before making any investment decisions. Algo is not regulated by OJK (Otoritas Jasa Keuangan) and does not provide any investment services. We are not responsible for any financial decisions you make based on the information provided. All content is presented with the intent of informing only.